2017
DOI: 10.1080/20018525.2017.1292378
|View full text |Cite
|
Sign up to set email alerts
|

Birt–Hogg–Dubé syndrome: a case report and a review of the literature

Abstract: Background: Birt-Hogg-Dubé syndrome (BHDS) is a rare autosomal dominant inherited syndrome caused by mutations in the folliculin coding gene (FLCN). The clinical manifestations of the syndrome involve the skin, lungs, and kidneys. Because of the rarity of the syndrome, guidelines for diagnosis and management of the patients with BHDS are lacking. Objective: To present a case story and a review of the literature on BHDS in order to give an update on genetics, clinical manifestations, diagnosis, treatment, progn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
32
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(35 citation statements)
references
References 72 publications
1
32
0
1
Order By: Relevance
“…Due to incomplete penetrance of clinical manifestations and marked variability in expression, BHD is generally assumed to be underdiagnosed. Symptomatic as well as nonsymptomatic individuals with BHD are advised regular renal cancer surveillance from age 20 years and specialized management of SP in order to reduce recurrence rate (Jensen et al., ; Menko et al., ).…”
Section: Introductionmentioning
confidence: 99%
“…Due to incomplete penetrance of clinical manifestations and marked variability in expression, BHD is generally assumed to be underdiagnosed. Symptomatic as well as nonsymptomatic individuals with BHD are advised regular renal cancer surveillance from age 20 years and specialized management of SP in order to reduce recurrence rate (Jensen et al., ; Menko et al., ).…”
Section: Introductionmentioning
confidence: 99%
“…Skin manifestations are also common in BHDS and are seen in approximately 58–90% of patients [21] . The involvement of the skin is benign, and no follow up is needed [24] .…”
Section: Discussionmentioning
confidence: 99%
“…And it is important that all patients suspected of having BHD should be offered genetic testing to confirm the diagnosis [26] . Infact, if a pathogenic FLCN mutation is identified, all at-risk relatives should be offered genetic counseling and predictive testing [24] .…”
Section: Discussionmentioning
confidence: 99%
“…More than 600 families have been diagnosed with BHD syndrome, but there are few reports in the literature describing an association between BHD syndrome and intracranial vascular pathology [1]. So far, these cases include two patients with intracranial aneurysms, one with an arteriovenous malformation (AVM) and one with carotid aplasia [2]. There is a hypothesized link between the BHD gene mutation and vascular pathology, although this is yet to be proven definitively [3][4][5].…”
Section: Introductionmentioning
confidence: 99%